BRPI0911907A2 - Mistura de triptofano ligado a peptídeo e de triptofano ligado a polipeptídeo - Google Patents
Mistura de triptofano ligado a peptídeo e de triptofano ligado a polipeptídeoInfo
- Publication number
- BRPI0911907A2 BRPI0911907A2 BRPI0911907-8A BRPI0911907A BRPI0911907A2 BR PI0911907 A2 BRPI0911907 A2 BR PI0911907A2 BR PI0911907 A BRPI0911907 A BR PI0911907A BR PI0911907 A2 BRPI0911907 A2 BR PI0911907A2
- Authority
- BR
- Brazil
- Prior art keywords
- tryptophan
- polypeptide
- peptide
- mixture
- linked
- Prior art date
Links
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 title 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 title 2
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
- 239000000203 mixture Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/08—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from eggs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08155315 | 2008-04-29 | ||
| EP08155315.8 | 2008-04-29 | ||
| PCT/EP2009/055038 WO2009133055A1 (en) | 2008-04-29 | 2009-04-27 | Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0911907A2 true BRPI0911907A2 (pt) | 2015-07-28 |
| BRPI0911907B1 BRPI0911907B1 (pt) | 2021-02-02 |
| BRPI0911907B8 BRPI0911907B8 (pt) | 2021-05-25 |
Family
ID=39811461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0911907A BRPI0911907B8 (pt) | 2008-04-29 | 2009-04-27 | processo para produzir uma composição contendo triptofano e composição proteica contendo triptofano |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8802088B2 (pt) |
| EP (1) | EP2268157B1 (pt) |
| JP (1) | JP5626807B2 (pt) |
| KR (1) | KR101698216B1 (pt) |
| CN (1) | CN102076228B (pt) |
| BR (1) | BRPI0911907B8 (pt) |
| EA (2) | EA029869B1 (pt) |
| ES (1) | ES2550463T3 (pt) |
| PL (1) | PL2268157T3 (pt) |
| WO (1) | WO2009133055A1 (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE548462T1 (de) | 2006-11-02 | 2012-03-15 | Dsm Ip Assets Bv | Verwendung von lysozymhydrolysaten enthaltend tryptophan |
| EP2282641B1 (en) * | 2008-04-29 | 2012-08-29 | DSM IP Assets B.V. | Composition comprising carbohydrates and peptides which comprise tryptophan |
| WO2009133055A1 (en) * | 2008-04-29 | 2009-11-05 | Dsm Ip Assets B.V. | Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan |
| CN103153326B (zh) | 2010-10-05 | 2015-08-19 | 帝斯曼知识产权资产管理有限公司 | 含有色氨酸的肽 |
| ES2651638T3 (es) | 2011-04-28 | 2018-01-29 | Dsm Ip Assets B.V. | Hidrolizados de proteínas como agentes para superar la adicción |
| US10194674B2 (en) | 2011-09-01 | 2019-02-05 | John C. Gilkey | Nutritional compositions |
| JP2013159591A (ja) * | 2012-02-08 | 2013-08-19 | Morinaga Milk Ind Co Ltd | 多動性抑制剤 |
| NZ702486A (en) * | 2012-11-02 | 2019-06-28 | Dsm Ip Assets Bv | Use of tryptophan rich protein hydrolysates |
| ES2828513T3 (es) | 2013-12-18 | 2021-05-26 | Dsm Ip Assets Bv | Composiciones que comprenden hidrolizado de lisozima para uso en tejido que contiene queratina |
| AU2016317046B2 (en) * | 2015-08-31 | 2022-03-10 | Nutramax Laboratories, Inc. | Compositions comprising magnolia, phellodendron, theanine and/or whey protein |
| US10591221B1 (en) | 2017-04-04 | 2020-03-17 | Mainstream Engineering Corporation | Advanced cooling system using throttled internal cooling passage flow for a window assembly, and methods of fabrication and use thereof |
| JP7139727B2 (ja) * | 2018-06-29 | 2022-09-21 | キリンホールディングス株式会社 | 運動制御機能および運動学習機能向上用組成物 |
| NL2022627B1 (en) | 2019-02-22 | 2020-08-31 | Newtricious Bv | Lysozyme hydrolysate for proactive inhibitory control and for attention |
| JP7428480B2 (ja) * | 2019-06-06 | 2024-02-06 | 雪印メグミルク株式会社 | 睡眠改善用組成物及び組成物を含む食品、医薬品、飼料 |
| US20220288125A1 (en) * | 2021-03-15 | 2022-09-15 | Stokely-Van Camp, Inc. | Nutritional Composition for Improving Sleep |
| CN120957737A (zh) * | 2023-03-29 | 2025-11-14 | 株式会社明治 | 多巴胺释放量增强剂、运动控制功能改善剂、运动学习功能改善剂以及活动欲望改善剂 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02279700A (ja) * | 1989-04-19 | 1990-11-15 | Asahi Chem Ind Co Ltd | 高トリプトファン含有ペプチド |
| FR2657013B1 (fr) * | 1990-01-18 | 1992-05-15 | Medgenix Group Sa | Composition dietetique a base de polypeptides et acides amines. |
| DK1339735T3 (da) * | 2000-12-06 | 2007-06-25 | Campina Nederland Holding Bv | Fremgangsmåde til fremstilling af tryptophanrige peptider |
| JP4221231B2 (ja) * | 2002-02-28 | 2009-02-12 | 株式会社ファーマフーズ | 抗菌組成物、その製造方法及び該抗菌組成物を含有する抗菌剤 |
| JP5019875B2 (ja) | 2004-04-19 | 2012-09-05 | キリンホールディングス株式会社 | 糖新生によりアルコール代謝を促進又は疲労を改善する組成物 |
| CN101022737B (zh) | 2004-07-22 | 2012-08-15 | 格罗伯斯卵类科学有限公司 | 抗高血压的功能性食品 |
| EP1685764A1 (en) * | 2005-01-27 | 2006-08-02 | Globus Egg Sciences B.V. | Anti-hypertensive functional food products |
| US7618669B2 (en) | 2005-06-01 | 2009-11-17 | Mead Johnson Nutrition Company | Low-lactose partially hydrolyzed infant formula |
| ATE548462T1 (de) * | 2006-11-02 | 2012-03-15 | Dsm Ip Assets Bv | Verwendung von lysozymhydrolysaten enthaltend tryptophan |
| WO2009133055A1 (en) | 2008-04-29 | 2009-11-05 | Dsm Ip Assets B.V. | Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan |
| EP2282641B1 (en) * | 2008-04-29 | 2012-08-29 | DSM IP Assets B.V. | Composition comprising carbohydrates and peptides which comprise tryptophan |
-
2009
- 2009-04-27 WO PCT/EP2009/055038 patent/WO2009133055A1/en not_active Ceased
- 2009-04-27 KR KR1020107026520A patent/KR101698216B1/ko active Active
- 2009-04-27 EA EA201400526A patent/EA029869B1/ru not_active IP Right Cessation
- 2009-04-27 BR BRPI0911907A patent/BRPI0911907B8/pt active IP Right Grant
- 2009-04-27 EA EA201001711A patent/EA021506B1/ru not_active IP Right Cessation
- 2009-04-27 EP EP09738099.2A patent/EP2268157B1/en active Active
- 2009-04-27 CN CN200980125142.8A patent/CN102076228B/zh active Active
- 2009-04-27 PL PL09738099T patent/PL2268157T3/pl unknown
- 2009-04-27 US US12/989,869 patent/US8802088B2/en active Active
- 2009-04-27 JP JP2011506670A patent/JP5626807B2/ja active Active
- 2009-04-27 ES ES09738099.2T patent/ES2550463T3/es active Active
-
2014
- 2014-07-10 US US14/327,683 patent/US9770493B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EA021506B1 (ru) | 2015-07-30 |
| CN102076228B (zh) | 2016-08-03 |
| ES2550463T3 (es) | 2015-11-10 |
| US20150037313A1 (en) | 2015-02-05 |
| EA029869B1 (ru) | 2018-05-31 |
| PL2268157T3 (pl) | 2015-12-31 |
| KR20100135319A (ko) | 2010-12-24 |
| US8802088B2 (en) | 2014-08-12 |
| CN102076228A (zh) | 2011-05-25 |
| WO2009133055A1 (en) | 2009-11-05 |
| KR101698216B1 (ko) | 2017-01-19 |
| EA201400526A1 (ru) | 2014-12-30 |
| US20110110919A1 (en) | 2011-05-12 |
| EP2268157A1 (en) | 2011-01-05 |
| BRPI0911907B1 (pt) | 2021-02-02 |
| EP2268157B1 (en) | 2015-08-19 |
| JP5626807B2 (ja) | 2014-11-19 |
| US9770493B2 (en) | 2017-09-26 |
| EA201001711A1 (ru) | 2011-06-30 |
| JP2011523547A (ja) | 2011-08-18 |
| BRPI0911907B8 (pt) | 2021-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0911907A2 (pt) | Mistura de triptofano ligado a peptídeo e de triptofano ligado a polipeptídeo | |
| EP2298731A4 (en) | AMIDE COMPOUND | |
| BRPI0907231A2 (pt) | pirrolpirimidinas e pirrolpiridinas | |
| SG10201400162QA (en) | Tgr5 modulators and methods of use thereof | |
| DK2349430T3 (da) | KATETERISERINGANORDNING og -kit | |
| ZA201104463B (en) | Compounds and methods of use | |
| BRPI0916735A2 (pt) | moduladores de tgr5 e métodos de uso do mesmo | |
| EP2340244A4 (en) | COMPOUNDS AND APPLICATION PROCEDURES | |
| BRPI0921992A2 (pt) | moduladores tgr5 e métodos de uso destes | |
| ZA201008483B (en) | Diazacarbazoles and methods of use | |
| EP2294227A4 (en) | CONCENTRATION TEST | |
| EP2349335A4 (en) | LEVETIRACETAM IMMUNOASSAYS | |
| BRPI0814876A2 (pt) | Análogos de pirona fosforilados e métodos | |
| BRPI0813681A2 (pt) | Detecção de coproantígeno de nematelminto | |
| BRPI0922150A2 (pt) | dispositivo de iluminação e dispositivo de vídeo | |
| IL209548A0 (en) | Diazacarbazoles and methods of use | |
| EP2321966A4 (en) | BRIGHTNESS EVALUATION | |
| DK2387466T3 (da) | Dekantercentrifuge og dekantercentrifuge-udledningsåbningselement | |
| DK2325662T3 (da) | Multi-indlæsnings- og multi-udlæsningsanalysator | |
| ZA201006932B (en) | Modulators of dopamine neurotransmission | |
| IT1397180B1 (it) | Componente micromeccanico | |
| FI20080112A0 (fi) | Seos | |
| ZA201007010B (en) | Rapid detection of mycobateria | |
| IL205044A0 (en) | Amide linked modulators of ?? - secretase | |
| DK2265778T3 (da) | Muranker |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 38/47 (2006.01), A23J 3/34 (2006.01), A23L 33 |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A23J 3/34 (2006.01), C12P 13/22 (2006.01), C12P 21 |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/02/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/04/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |